Previous small clinical trials found that atorvastatin decreases ALT serum levels while improving hepatic steatosis [276], and that rosuvastatin reduces both ALT and AST serum levels with amelioration of liver fibrosis [277]. Here, GPT is linked to Hepatic fibrosis.